the market?
Ariad Pharmaceuticals, Inc.
NASDAQ: ARIA
16.67
0.20
(1.21%)
| Today's Open | $16.66 |
|---|---|
| Previous Close | $16.47 |
| Daily Range | $16.40 - $16.85 |
| 52-Week Range | $15.13 - $25.40 |
| Market Cap | $3.1B |
| P/E Ratio | -12.20 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,261,521 |
| Average Daily Volume | 2,962,221 |
| Current FY EPS | -$1.66 |
How do you think ARIA
will perform against the market?
Top ARIA Bull/Bear Pitches
JesusForgives (< 20)
Submitted
April 1, 2010
This stock could just be a good pick to do a cover call option for may10 if my figures are right you could see a return of 14% for the month.
zzlangerhans (< 20)
Submitted
December 2, 2010
Ariad's share price has bounced around a lot this year in advance of data from the phase III SUCCEED trial of ridaforolimus in metastatic sarcoma, and is now close to a three year high (and a six-year … More
News & Commentary
3 Companies That Put the "Tech" in "Biotech"
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."What’s Moving These Biotech Stocks?
What’s Moving These Biotech Stocks?Does Ariad's Leukemia Drug Have Hidden Potential?
Ariad's Iclusig launch is beating Wall Street, but should investors join the ride?Sector
Healthcare
Industry
Drugs
Ariad Pharmaceuticals, Inc. (ARIA) Description
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/
